Baljiwan Medicines Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.30 M
- Company Age 35 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.23 Cr
- Satisfied Charges ₹ 5.25 M
- Revenue Growth 25.97%
- Profit Growth 5.15%
- Ebitda 50.46%
- Net Worth 4.89%
- Total Assets 8.86%
About Baljiwan Medicines
Baljiwan Medicines Private Limited (BMPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 1989 and has a history of 35 years and four months. Its registered office is in Uttar Pradesh, Uttar Pradesh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.30 M.
The company currently has active open charges totaling ₹1.23 Cr. The company has closed loans amounting to ₹5.25 M, as per Ministry of Corporate Affairs (MCA) records.
Richa Agrawal and Saurabh Agarwal serve as directors at the Company.
Company Details
-
LocationUttar Pradesh, Uttar Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231UP1989PTC011170
-
Company No.
011170
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Sep 1989
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Baljiwan Medicines Private Limited offer?
Baljiwan Medicines Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Churna and Goli, Common Disease Medicines, Pharmaceutical Capsules, Ayurvedic Herbal Syrups & Tonics.
Who are the key members and board of directors at Baljiwan Medicines?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Richa Agrawal
|
Director | 20-Apr-2015 | Current |
|
Saurabh Agarwal
|
Director | 20-Apr-2015 | Current |
Financial Performance of Baljiwan Medicines.
Baljiwan Medicines Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 25.97% increase. The company also saw a slight improvement in profitability, with a 5.15% increase in profit. The company's net worth moved up by a moderate rise of 4.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Baljiwan Medicines?
In 2021, Baljiwan Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Baljiwan Herbal Care Private LimitedSaurabh Agarwal is a mutual person
-
Eleven Metal Products Private Limited
Saurabh Agarwal is a mutual person
Charges (Loans)
₹12.25 M
₹5.25 M
Charges Breakdown by Lending Institutions
- Canara Bank : 1.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2022 | Canara Bank | ₹1.00 M | Open |
| 21 Aug 2017 | Canara Bank | ₹1.25 M | Open |
| 21 Aug 2017 | Canara Bank | ₹1.00 Cr | Open |
| 15 Apr 2020 | Canara Bank | ₹3.50 M | Satisfied |
| 31 Mar 2018 | Canara Bank | ₹1.75 M | Satisfied |
How Many Employees Work at Baljiwan Medicines?
Baljiwan Medicines has a workforce of 22 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Baljiwan Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baljiwan Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
